Turn this role into an interview — a resume and cover letter built around what this employer wants.
Pfizer seeks a Senior Leader to envision and implement next-generation immunodiagnostics strategies in the Vaccines R&D Clinical Immunology and Diagnostics group. You will drive high-throughput, automated LBA approaches and lead a team of scientists to support vaccine trials and epidemiological studies.
You will collaborate across vaccine program teams, manage multiple projects, and ensure all work adheres to GCLP/cGMP standards while advancing automation and DoE-driven analytics.
As a Senior Leader within the Vaccines R&D Clinical Immunology and Diagnostics organization, you will envision and implement next‑generation immunodiagnostics strategies. Reporting to the Head of Clinical Diagnostics, you will drive novel, high‑throughput ligand binding assay (LBA) strategies outside conventional plate‑based assays, focusing heavily on automation, speed, and high precision. You will lead a high‑performing team developing and maintaining immunodiagnostic assays to support vaccine clinical trials and epidemiological studies, and serve as the primary immunology and assay development SME for vaccine program teams.
This is a hybrid role requiring on‑site work an average of 2.5 days per week or more as needed. Relocation support may be available.
Sitting for long periods of time and occasional walking from one building to another.
Annual base salary range: $176,600 – $294,300. Eligible for the Global Performance Plan with a bonus target of 20% of base salary and participation in Pfizer’s share‑based long‑term incentive program. Comprehensive benefits include a 401(k) plan with corporate matching, paid vacation, holiday and personal days, caregiver/parental and medical leave, and medical, prescription drug, dental and vision coverage.
Pfizer is committed to equal opportunity in employment. Candidates must be authorized to work permanently in the United States. Pfizer does not sponsor U.S. work visas for this role.